Literature DB >> 32794674

[Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)].

.   

Abstract

Novel coronavirus pneumonia is a new type of respiratory infectious disease that has rapidly spread in many countries or regions around the world. The World Health Organization (WHO) named it "coronavirus disease 2019 (COVID-19)". Glucocorticoids (GC) have certain application value in patients with COVID-19, but they need to be used with caution and strict indications and dosage. Application of large doses of GC can also cause osteonecrosis of femoral head (ONFH). On the basis of the latest literature and evidence-based medical evidence on the fight against COVID-19 epidemic and steroid ONFH diagnosis and treatment, the Bone Circulation and Osteonecrosis Professional Committee, Shockwave Medical Specialty Committee of Chinese Research Hospital Association organized Chinese bone necrosis related experts to jointly write this consensus, focusing on the prevention strategy and the protective management measures in the ONFH diagnosis and treatment process during the prevention and control of COVID-19, which can provide reference for hospitals at all levels to carry out early prevention and treatment of ONFH.

Entities:  

Keywords:  Novel coronavirus pneumonia; disease prevention and control; expert consensus; osteonecrosis of femoral head

Mesh:

Year:  2020        PMID: 32794674      PMCID: PMC8171914          DOI: 10.7507/1002-1892.202003068

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  14 in total

Review 1.  Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update.

Authors:  Michael A Mont; Jeffrey J Cherian; Rafael J Sierra; Lynne C Jones; Jay R Lieberman
Journal:  J Bone Joint Surg Am       Date:  2015-10-07       Impact factor: 5.284

2.  Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study.

Authors:  Tomonori Shigemura; Junichi Nakamura; Shunji Kishida; Yoshitada Harada; Seiji Ohtori; Koya Kamikawa; Nobuyasu Ochiai; Kazuhisa Takahashi
Journal:  Rheumatology (Oxford)       Date:  2011-08-24       Impact factor: 7.580

3.  Early detection of avascular necrosis of the femoral head following renal transplantation.

Authors:  B Fink; S Degenhardt; C Paselk; T Schneider; U Mödder; W Rüther
Journal:  Arch Orthop Trauma Surg       Date:  1997       Impact factor: 3.067

4.  [Clinical research of correlation between osteonecrosis and steroid].

Authors:  Zi-rong Li; Wei Sun; Hui Qu; Yi-xiong Zhou; Bao-xin Dou; Zhen-cai Shi; Nian-fei Zhang; Xiao-guang Cheng; Da-li Wang; Wan-shou Guo
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2005-08-15

5.  Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids.

Authors:  James Francis Griffith; Gregory Ernest Antonio; Shekhar Madhukar Kumta; David Shu Cheong Hui; Jeffrey Ka Tak Wong; Gavin Matthew Joynt; Alan Ka Lun Wu; Albert Yu Kiu Cheung; Kwok Hing Chiu; Kai Ming Chan; Ping Chung Leung; Anil Tejbhan Ahuja
Journal:  Radiology       Date:  2005-02-09       Impact factor: 11.105

6.  Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.

Authors:  Yaseen M Arabi; Yasser Mandourah; Fahad Al-Hameed; Anees A Sindi; Ghaleb A Almekhlafi; Mohamed A Hussein; Jesna Jose; Ruxandra Pinto; Awad Al-Omari; Ayman Kharaba; Abdullah Almotairi; Kasim Al Khatib; Basem Alraddadi; Sarah Shalhoub; Ahmed Abdulmomen; Ismael Qushmaq; Ahmed Mady; Othman Solaiman; Abdulsalam M Al-Aithan; Rajaa Al-Raddadi; Ahmed Ragab; Hanan H Balkhy; Abdulrahman Al Harthy; Ahmad M Deeb; Hanan Al Mutairi; Abdulaziz Al-Dawood; Laura Merson; Frederick G Hayden; Robert A Fowler
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

7.  Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.

Authors:  Nelson Lee; K C Allen Chan; David S Hui; Enders K O Ng; Alan Wu; Rossa W K Chiu; Vincent W S Wong; Paul K S Chan; K T Wong; Eric Wong; C S Cockram; John S Tam; Joseph J Y Sung; Y M Dennis Lo
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

8.  Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.

Authors:  Rong-Chang Chen; Xiao-Ping Tang; Shou-Yong Tan; Bi-Ling Liang; Zhuo-Yue Wan; Ji-Qian Fang; Nanshan Zhong
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

9.  The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study.

Authors:  Tung Wai Auyeung; Jenny S W Lee; Wing Kin Lai; Chun Hung Choi; Hoi Kan Lee; Joo Shim Lee; Po Chun Li; Ka Ho Lok; Yuk Yung Ng; Wai Ming Wong; Yiu Ming Yeung
Journal:  J Infect       Date:  2005-08       Impact factor: 6.072

10.  Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Authors:  Gerard Moreno; Alejandro Rodríguez; Luis F Reyes; Josep Gomez; Jordi Sole-Violan; Emili Díaz; María Bodí; Sandra Trefler; Juan Guardiola; Juan C Yébenes; Alex Soriano; José Garnacho-Montero; Lorenzo Socias; María Del Valle Ortíz; Eudald Correig; Judith Marín-Corral; Montserrat Vallverdú-Vidal; Marcos I Restrepo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Intensive Care Med       Date:  2018-08-03       Impact factor: 17.440

View more
  1 in total

1.  General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19.

Authors:  Wenlong Li; Zeqing Huang; Biao Tan; Gang Chen; Xugui Li; Kan Xiong; Ruizheng Zhu; Ruihan Li; Shuwen Li; Hengli Ye; Zhi Liang; Xiaojun Dong; Shijing Zhou; Song Chen; Haixiang Xi; Hao Cheng; Rongpeng Xu; Shenghao Tu; Zhe Chen; Lihua Qi; Jiandong Song; Ruoran Xiao; Huilan Liu; Qian Nan; Huiyong Yu; Hongsheng Cui; Yanguang Shen; Chengxiang Wang; Na Lin; Yanqiong Zhang; Weiheng Chen
Journal:  J Orthop Translat       Date:  2021-10-20       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.